Progression of liver fibrosis in<scp>HIV</scp>/hepatitis<scp>C</scp>virus‐coinfected individuals on antiretroviral therapy with early stages of liver fibrosis at baseline

Abstract

A high proportion of patients with stage F0-F2 fibrosis progress to advanced liver fibrosis. Advanced liver fibrosis must be included in the list of diseases associated with aging. Our results support the recommendation to offer HCV antiviral therapy to HIV/HCV-coinfected patients at early stages of liver fibrosis.